Preliminary Efficacy and Safety of Camrelizumab Combined with Cetuximab and Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): A Phase II Clinical Trial.
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要